Ratios

		vs industry	vs history
P/B	0.40	HRT's P/B is ranked higher than 85% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.99 vs. HRT: 0.40 )	HRT' s 10-Year P/B Range Min: 0.26   Max: 12.47 Current: 0.4 0.26 12.47
P/S	0.30	HRT's P/S is ranked higher than 93% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.70 vs. HRT: 0.30 )	HRT' s 10-Year P/S Range Min: 0.2   Max: 14.62 Current: 0.3 0.2 14.62
EV-to-EBIT	5.2	HRT's EV-to-EBIT is ranked higher than 53% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 16.25 vs. HRT: 5.2 )	HRT' s 10-Year EV-to-EBIT Range Min: 4   Max: 326.2 Current: 5.2 4 326.2

Dividend & Buy Back

		vs industry	vs history
Dividend Yield	1.10	HRT's Dividend Yield is ranked higher than 73% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.71 vs. HRT: 1.10 )	HRT' s 10-Year Dividend Yield Range Min: 0.12   Max: 4.09 Current: 1.1 0.12 4.09
Yield on cost (5-Year)	1.10	HRT's Yield on cost (5-Year) is ranked higher than 72% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.76 vs. HRT: 1.10 )	HRT' s 10-Year Yield on cost (5-Year) Range Min: 0.12   Max: 4.09 Current: 1.1 0.12 4.09
Share Buyback Rate	-0.7	HRT's Share Buyback Rate is ranked higher than 75% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: -1.05 vs. HRT: -0.7 )	HRT' s 10-Year Share Buyback Rate Range Min: 6.6   Max: -6.2 Current: -0.7

Valuation & Return

		vs industry	vs history
Price/Net Current Asset Value	2	HRT's Price/Net Current Asset Value is ranked higher than 53% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 8.90 vs. HRT: 2 )	HRT' s 10-Year Price/Net Current Asset Value Range Min: 1.4   Max: 37.4 Current: 2 1.4 37.4
Price/Tangible Book	0.5	HRT's Price/Tangible Book is ranked lower than 61% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 3.80 vs. HRT: 0.5 )	HRT' s 10-Year Price/Tangible Book Range Min: 0.4   Max: 10.8 Current: 0.5 0.4 10.8
Price/DCF (Projected)	1.4	HRT's Price/DCF (Projected) is ranked higher than 72% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.25 vs. HRT: 1.4 )	HRT' s 10-Year Price/DCF (Projected) Range Min: 0.3   Max: 4.6 Current: 1.4 0.3 4.6
Price/Median PS Value	0.3	HRT's Price/Median PS Value is ranked lower than 55% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 0.80 vs. HRT: 0.3 )	HRT' s 10-Year Price/Median PS Value Range Min: 0.2   Max: 10.6 Current: 0.3 0.2 10.6
Forward Rate of Return (Yacktman)	1.13	HRT's Forward Rate of Return (Yacktman) is ranked higher than 77% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 3.03 vs. HRT: 1.13 )	HRT' s 10-Year Forward Rate of Return (Yacktman) Range Min: -13.2   Max: 41.8 Current: 1.13 -13.2 41.8

Business Description

Arrhythmia Research Technology is a Delaware corporation, through its wholly-owned subsidiaries is a diverse component and device manufacturer, software and medical technology service provider. The Company has three operating business segments. In the first segment, its subsidiary, Micron Products, Inc., a Delaware corporation is the Company's primary source of consolidated revenues. Micron's largest product category of revenue relates to its manufacture and sale of silver plated and non-silver plated conductive resin sensors used in the manufacture of disposable ECG, EEG, EMS and TENS electrodes. In an effort to leverage these skills, the Company has expanded into custom thermoplastic injection molded products with a full array of design, engineering and production services and management. With the addition of a medical machining cell, the Company began production of patient specific metal and plastic orthopedic devices. The second segment is medical monitoring services provided through ART's subsidiary, RMDDxUSA Corp., a Delaware corporation, and RMDDxUSA's Canadian subsidiary, RMDDx Corporation, branded 'WirelessDx'. WirelessDx is dedicated to the development and commercialization of medical devices and services, medical information technology, medical diagnostics and remote patient monitoring through wireless, Internet and telecommunication technologies. The Company's third business segment, computerized medical instruments, distributes its customizable proprietary signal-averaging electrocardiography (SAECG) software used in the detection of potentially lethal heart arrhythmias and that is reconfigurable for a variety of hardware platforms. Micron sells its sensors to large, sophisticated OEM manufacturers of disposable snap type and radio translucent ECG electrodes who compete internationally in the electrode market against other OEM manufacturers as well as manufacturers of tab-type electrodes. The Company has one major domestic competitor in the sensor market along with an increasing number of minor competitors worldwide. The Company markets Micron and its MIT division as a highly specialized custom injection thermoplastic molder to new and existing customers. The Company competes with respect to its sensor products on the basis of pricing, technical capabilities, quality of service and ability to meet customer requirements. The Company's software products are subject to material clearance and distribution requirements from governmental regulatory authorities, mainly the U.S. Food and Drug Administration (FDA) and the European Union (EU) equivalent agency.
Company Website
SEC Reports

Industry:	Medical Devices
Compare:	MDT, SYK, SMA, ZMH, STJ

» More Articles for HRT

Headlines

Articles On GuruFocus.com

Longleaf Partners Believe HRT Could Be Their Most Exciting Investment Ever Jun 08 2011

Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Nov 10 2010

Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Aug 16 2010

Arrhythmia Research Technology Inc Reports Operating Results (10-Q) May 04 2010

Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Oct 30 2009

Weekly CFO Buys Highlight: Protection One Inc., Rocky Brands Inc., Arrhythmia Research Technology In Sep 19 2009

Arrhythmia Research Technology Inc (HRT) CFO David A Garrison buys 5,000 Shares Sep 17 2009

Weekly CFO Buy Highlights: Angiotech Pharmaceuticals, Seacoast Banking Corp., TranSwitch Corp., Apol Aug 22 2009

Weekly CFO Buys Highlight: Arrhythmia Research Technology, Ultra Clean Holdings, Pixelworks, Hospira Aug 16 2009

Arrhythmia Research Technology Inc (HRT) CFO David A Garrison buys 5,000 Shares Aug 12 2009

Personalized Checklist